Healthcare stocks are mixed, with the NYSE Healthcare Sector
Index rising 0.5% while shares of healthcare companies in the
S&P 500 are down nearly 0.5% as a group.
In company news, Prima Biomed Ltd. (
) is down nearly 35% at $1.53 a share, climbing off a new 52-week
low of $1.26 that followed the biotech company's saying its CVac
drug candidate failed to show statistically significant improvement
in patient survival in Phase II testing in patients with epithelial
ovarian cancer patients in first or second remission.
The company said the study was not adequately powered to detect
statistical significance, and the estimate of median
progression-free survival for all randomized patients resulted in
no observed difference between the prospective cancer vaccine and
But the company said it believes it is still too early to make
conclusions based on overall survival data, adding it will continue
to monitor patient outcomes from the current trial until overall
survival data matures.
In other sector news,
(+) ATOS (+29.9%) McKesson's (
) medical-surgical unit will distribute and sell Atossa Genetic's
MASCT device and patient collection kits nationwide.
(-) AGEN, (-3.3%) Reaches agreements to sell nearly 2.2 million
shares to institutional investors, generating $6.5 mln in gross
proceeds. The deal also includes five-year warrants to buy up to
650,000 more shares, exercisable at $3.75 starting in six